```json
{"content":[{"type":"paragraph","content":"Central Vascular Access Devices, or CVADs, are sterile catheters inserted into large veins to deliver treatments and enable monitoring for critical, cancer, and long-term chronic therapy. The global Central Vascular Access Devices market size is projected to reach USD 3.2 billion in 2025 (base year) and climb to roughly USD 4.8 billion by 2033, underlining a growth outlook of ~5.6% CAGR over the market forecast period. Chronic-disease escalation, ageing populations, and a shift to home-based infusion are fuelling industry expansion; providers seek catheter-to-port systems that cut infection risk and streamline workflows. Technology shifts (ultrasound-guided insertion, antimicrobial polymer linings), regulatory tightening (FDA safety orders, EU MDR), plus supply-chain rationalization (US domestic sourcing, China dual-sourcing) frame the strategic backdrop. North America remains the largest region due to high surgical volumes and value-based procurement, while Asia-Pacific is the fastest-growing market thanks to large oncology cases and accelerated healthcare investment.","content":[{"type":"chart","chartType":"segment-stacked","data":{"segments":["Peripherally Inserted Central Catheters (PICCs)","Central Venous Catheters (CVCs)","Ports/Access Port","Tunneled Cuffed Catheters","Midline Catheters"],"periods":["2026","2027","2008","2029","2030","2031","2032","2033"],"values":[[640,690,740,790,850,910,970,1040],[610,650,700,750,800,860,920,990],[480,520,560,600,650,700,750,810],[340,360,390,420,450,480,520,560],[230,250,270,290,310,330,350,380]}}]]}
```
